Please login to the form below

Not currently logged in
Email:
Password:

Almirall expands to UK

Spanish pharma company, Almirall, has marked its expansion into the UK market with the opening of new London headquarters

Spanish pharma company, Almirall, has marked its expansion into the UK market with the opening of new London headquarters on April 24. 

Almirall UK offers a widening product portfolio, primarily focused on dermatology and currently comprising 14 medicines.

The new offices, near Heathrow airport, will house 50 staff covering the market in the UK and Ireland. The company has a number of dermatology products covering a range of conditions and will be bringing additional products to the UK market soon.

Government Business Secretary, Peter Mandelson, opened the offices, saying: "It is my pleasure to welcome Almirall to the UK. As the Government's strategy, 'Building Britain's Future', states, we are committed to helping companies to invest in Britain as well as safeguard the jobs this investment supports. Almirall's decision to expand here is a clear recognition of the UK's strengths as a modern, knowledge-based economy, where we have the skills and regulatory environment to compete effectively in high-tech, high value sectors such as pharmaceuticals."

Following the acquisition of products from Shire and the purchase of German dermalogical company, Hermal, Almirall UK will focus on dermatological disease treatments, including Solaraze, for keratosis actinica, and Vaniqa for facial hirsutism, Balneum, Balneum Plus, and Unguentum for eczema and skin infections, Aknemicin, and Aknemicin plus for acne and Curatoderm for psoriasis.

Almirall UK will market the company's R&D products, such us the anti-inflammatory Preservex (aceclofenac) and Almogran (almotriptan) for the treatment of migraine.

Almirall conducts research into the treatment of asthma, Chronic Obstructive Pulmonary Disease, rheumatoid arthritis, multiple sclerosis, psoriasis and dermatology.

29th April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics